GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (NYSE:NVO) » Definitions » Shiller PE Ratio

NVO (Novo Nordisk AS) Shiller PE Ratio : 37.17 (As of Apr. 25, 2025)


View and export this data going back to 1981. Start your Free Trial

What is Novo Nordisk AS Shiller PE Ratio?

As of today (2025-04-25), Novo Nordisk AS's current share price is $62.08. Novo Nordisk AS's E10 for the quarter that ended in Dec. 2024 was $1.67. Novo Nordisk AS's Shiller PE Ratio for today is 37.17.

The historical rank and industry rank for Novo Nordisk AS's Shiller PE Ratio or its related term are showing as below:

NVO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 25.12   Med: 38.73   Max: 92.94
Current: 33.56

During the past years, Novo Nordisk AS's highest Shiller PE Ratio was 92.94. The lowest was 25.12. And the median was 38.73.

NVO's Shiller PE Ratio is ranked worse than
68.91% of 521 companies
in the Drug Manufacturers industry
Industry Median: 23.88 vs NVO: 33.56

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novo Nordisk AS's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.890. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.67 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novo Nordisk AS Shiller PE Ratio Historical Data

The historical data trend for Novo Nordisk AS's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Shiller PE Ratio Chart

Novo Nordisk AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.03 47.09 52.82 68.12 51.56

Novo Nordisk AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.12 81.44 90.42 67.69 51.56

Competitive Comparison of Novo Nordisk AS's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Novo Nordisk AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk AS's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novo Nordisk AS's Shiller PE Ratio falls into.


;
;

Novo Nordisk AS Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novo Nordisk AS's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=62.08/1.67
=37.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Nordisk AS's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Novo Nordisk AS's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.89/118.9000*118.9000
=0.890

Current CPI (Dec. 2024) = 118.9000.

Novo Nordisk AS Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.275 100.200 0.326
201506 0.243 100.300 0.288
201509 0.245 100.200 0.291
201512 0.236 99.800 0.281
201603 0.277 100.200 0.329
201606 0.296 100.600 0.350
201609 0.291 100.200 0.345
201612 0.245 100.300 0.290
201703 0.292 101.200 0.343
201706 0.303 101.200 0.356
201709 0.317 101.800 0.370
201712 0.267 101.300 0.313
201803 0.364 101.700 0.426
201806 0.334 102.300 0.388
201809 0.292 102.400 0.339
201812 0.269 102.100 0.313
201903 0.330 102.900 0.381
201906 0.305 102.900 0.352
201909 0.316 102.900 0.365
201912 0.275 102.900 0.318
202003 0.373 103.300 0.429
202006 0.342 103.200 0.394
202009 0.350 103.500 0.402
202012 0.328 103.400 0.377
202103 0.436 104.300 0.497
202106 0.426 105.000 0.482
202109 0.417 105.800 0.469
202112 0.362 106.600 0.404
202203 0.461 109.900 0.499
202206 0.416 113.600 0.435
202209 0.422 116.400 0.431
202212 0.429 115.900 0.440
202303 0.631 117.300 0.640
202306 0.629 116.400 0.643
202309 0.716 117.400 0.725
202312 0.718 116.700 0.732
202403 0.828 118.400 0.831
202406 0.648 118.500 0.650
202409 0.911 118.900 0.911
202412 0.890 118.900 0.890

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novo Nordisk AS  (NYSE:NVO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novo Nordisk AS Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk AS Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, 2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.